{"id":"W2466007724","doi":"10.1212/wnl.84.14_supplement.p7.278","title":"Improvement in Clinical Outcomes Following Switch From Subcutaneous Interferon Beta-1a to Alemtuzumab: CARE-MS II Extension Study (P7.278)","year":2015,"lang":"en","type":"article","venue":"Neurology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"","keywords":"Alemtuzumab; Medicine; BETA (programming language); Interferon beta; Interferon beta-1b; Interferon beta-1a; Oncology; Internal medicine; Interferon; Immunology; Antibody; Computer science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001963791,0.0008198387,0.001689338,0.0002270858,0.0003752318,0.0005292408,0.000512721,0.0007173133,0.001916581],"category_scores_gemma":[0.001499624,0.000248573,0.000839874,0.0002892428,0.0003669054,0.0003806556,0.0002974204,0.001284158,0.000426773],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005825995,"about_ca_system_score_gemma":0.0009124803,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000948736,"about_ca_topic_score_gemma":0.001357193,"domain_scores_codex":[0.9992961,0.0003048897,0.00004918746,0.0001572546,0.00008888404,0.0001036763],"domain_scores_gemma":[0.998733,0.0001470092,0.0003476369,0.0001437904,0.0001716328,0.0004569003],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7474357,0.03355853,0.09907724,0.0005053601,0.002408573,0.0003962321,0.0002614855,0.0009624233,0.02667886,0.0000817071,0.004889645,0.08374418],"study_design_scores_gemma":[0.1922654,0.3825701,0.4126656,0.00009840483,0.001636045,0.0006724282,0.00006637102,0.001427072,0.005591256,0.0001101618,0.00284451,0.00005263445],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9978661,0.0005216682,0.00007507323,0.00004400542,0.0000216578,0.0003004444,0.0004197972,0.00001928362,0.0007320346],"genre_scores_gemma":[0.9961239,0.0002193888,0.0002938613,0.0002810319,0.00008615521,0.0004039614,0.002002062,0.000006053396,0.0005835068],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001963791,"threshold_uncertainty_score":0.01038563,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07580340853530435,"score_gpt":0.397110148028157,"score_spread":0.3213067394928526,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}